Eliminating racial bias in pulse oximetry has been top of mind lately for many devicemakers and healthcare providers, as well as the FDA, which convened an advisory committee meeting earlier this ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today FDA clearance of MightySat ® Medical, making it the first and only FDA-cleared medical fingertip pulse oximeter available ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the CE marking of Eve™, a critical congenital heart disease (CCHD) newborn screening application, for the Rad-97™ Pulse ...

Masimo iSpO2 pulse oximeter and the iSpO2 app. Manufactured and submitted by Masimo Corp. (Irvine, CA). The iSpO2 is a measure-through-motion and low-perfusion pulse oximeter made for iPhone and iPad.

Masimo Corporation MASI recently announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter (OTC) to consumers without a prescription. This ...

Masimo Corp.’s pulse oximetry technology avoids the dangerous under-recognition of low oxygen levels in people of color that plagues many pulse oximeters on the market, a peer-reviewed study in the ...

Wearable devices have become essential to clinical research, as they enable research studies to collect health-related data on patients around the clock. These devices, which includes commercial ...

In mid-2021, medical technology company Masimo sued Apple over the Watch Series 6's blood oxygen monitoring capabilities. Masimo accused the tech giant of infringing on five of its pulse oximeter ...

Apple on Thursday began selling revised models of the Apple Watch Series 9 and Ultra 2 in the US without the blood oxygen feature as the company faces a patent dispute with medical company Masimo. In ...

Joe Kiani, Founder and CEO of Masimo, said, “Until now, consumers and even healthcare providers had no way of knowing what pulse oximeter they could trust to use at home. On the internet and even in ...